thanks for pointing it out anyway; if there was a fund that held listed hybrids (that I liked) and that fund or share was trading below NTA, I of course would buy it
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
